ArticleCell proliferation2017

Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1.

Zhili Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.